Remarkably, however, platelet-derived soluble CD84 acts on CD4 + T cell CD84 leading to enhanced CD4 + T cell motility in vitro and aggravated infarct growth following experimental stroke [120]. This evidence concerns the gene CD4 and stroke disorder.